

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of pigment cell differentiation (GO:0050932) | 4.83662763 |
| 2 | interkinetic nuclear migration (GO:0022027) | 4.77826184 |
| 3 | positive regulation of developmental pigmentation (GO:0048087) | 4.70025158 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.61350312 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.61350312 |
| 6 | establishment of protein localization to Golgi (GO:0072600) | 4.58714665 |
| 7 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.58435814 |
| 8 | cytoplasmic mRNA processing body assembly (GO:0033962) | 4.41105907 |
| 9 | regulation of establishment of cell polarity (GO:2000114) | 4.33303006 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.24287770 |
| 11 | regulation of translation, ncRNA-mediated (GO:0045974) | 4.17603002 |
| 12 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 4.17603002 |
| 13 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 4.17603002 |
| 14 | snRNA transcription (GO:0009301) | 4.17005562 |
| 15 | cellular response to ethanol (GO:0071361) | 4.06875103 |
| 16 | lipid translocation (GO:0034204) | 4.05512347 |
| 17 | phospholipid translocation (GO:0045332) | 4.05512347 |
| 18 | protein K48-linked deubiquitination (GO:0071108) | 4.03593208 |
| 19 | protein targeting to vacuole (GO:0006623) | 3.84437353 |
| 20 | protein targeting to lysosome (GO:0006622) | 3.84437353 |
| 21 | establishment of protein localization to vacuole (GO:0072666) | 3.84437353 |
| 22 | histone H3-K4 trimethylation (GO:0080182) | 3.77573549 |
| 23 | endosome to pigment granule transport (GO:0043485) | 3.73886102 |
| 24 | endosome to melanosome transport (GO:0035646) | 3.73886102 |
| 25 | protein K11-linked deubiquitination (GO:0035871) | 3.71187950 |
| 26 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.69866515 |
| 27 | indolalkylamine metabolic process (GO:0006586) | 3.66783332 |
| 28 | alpha-linolenic acid metabolic process (GO:0036109) | 3.66253582 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.52510418 |
| 30 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.38130324 |
| 31 | signal peptide processing (GO:0006465) | 3.36563241 |
| 32 | neural tube formation (GO:0001841) | 3.36368375 |
| 33 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.35447077 |
| 34 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.34811223 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.33873974 |
| 36 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.33227188 |
| 37 | pericardium development (GO:0060039) | 3.33034316 |
| 38 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.28237437 |
| 39 | sulfur amino acid catabolic process (GO:0000098) | 3.26231119 |
| 40 | protein K63-linked deubiquitination (GO:0070536) | 3.24003280 |
| 41 | regulation of hippo signaling (GO:0035330) | 3.23666032 |
| 42 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.17782358 |
| 43 | protein targeting to Golgi (GO:0000042) | 3.16349114 |
| 44 | valine metabolic process (GO:0006573) | 3.15292282 |
| 45 | behavioral response to nicotine (GO:0035095) | 3.14369423 |
| 46 | negative regulation of sodium ion transport (GO:0010766) | 3.14026569 |
| 47 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.12592402 |
| 48 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.07203443 |
| 49 | regulation of cholesterol homeostasis (GO:2000188) | 3.04445933 |
| 50 | regulation of triglyceride catabolic process (GO:0010896) | 3.02170493 |
| 51 | urea cycle (GO:0000050) | 3.02023112 |
| 52 | urea metabolic process (GO:0019627) | 3.02023112 |
| 53 | oxidative demethylation (GO:0070989) | 3.00053890 |
| 54 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.98003197 |
| 55 | L-phenylalanine catabolic process (GO:0006559) | 2.98003197 |
| 56 | phospholipid efflux (GO:0033700) | 2.97781966 |
| 57 | mannose metabolic process (GO:0006013) | 2.97456445 |
| 58 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.96068069 |
| 59 | ethanol oxidation (GO:0006069) | 2.95228043 |
| 60 | regulation of gamma-delta T cell activation (GO:0046643) | 2.94305025 |
| 61 | nucleus localization (GO:0051647) | 2.93821087 |
| 62 | protein carboxylation (GO:0018214) | 2.89087701 |
| 63 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.89087701 |
| 64 | cysteine metabolic process (GO:0006534) | 2.88802426 |
| 65 | L-phenylalanine metabolic process (GO:0006558) | 2.85478456 |
| 66 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.85478456 |
| 67 | negative regulation of protein localization to cell surface (GO:2000009) | 2.84642470 |
| 68 | negative regulation of cholesterol transport (GO:0032375) | 2.84027680 |
| 69 | negative regulation of sterol transport (GO:0032372) | 2.84027680 |
| 70 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.83738065 |
| 71 | high-density lipoprotein particle remodeling (GO:0034375) | 2.83627206 |
| 72 | L-fucose catabolic process (GO:0042355) | 2.83612784 |
| 73 | fucose catabolic process (GO:0019317) | 2.83612784 |
| 74 | L-fucose metabolic process (GO:0042354) | 2.83612784 |
| 75 | cardiovascular system development (GO:0072358) | 2.83187483 |
| 76 | reverse cholesterol transport (GO:0043691) | 2.82942782 |
| 77 | peptidyl-lysine methylation (GO:0018022) | 2.82602431 |
| 78 | thyroid hormone metabolic process (GO:0042403) | 2.82465299 |
| 79 | growth hormone receptor signaling pathway (GO:0060396) | 2.82111104 |
| 80 | complement activation, alternative pathway (GO:0006957) | 2.81153422 |
| 81 | detection of light stimulus involved in visual perception (GO:0050908) | 2.79542614 |
| 82 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.79542614 |
| 83 | cellular response to exogenous dsRNA (GO:0071360) | 2.78130692 |
| 84 | indole-containing compound metabolic process (GO:0042430) | 2.76319012 |
| 85 | peptidyl-lysine trimethylation (GO:0018023) | 2.75224979 |
| 86 | regulation of sarcomere organization (GO:0060297) | 2.74762987 |
| 87 | phospholipid homeostasis (GO:0055091) | 2.73361128 |
| 88 | flavonoid metabolic process (GO:0009812) | 2.73237371 |
| 89 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.72654258 |
| 90 | ethanol metabolic process (GO:0006067) | 2.72136270 |
| 91 | hepatocyte apoptotic process (GO:0097284) | 2.71711255 |
| 92 | aromatic amino acid family catabolic process (GO:0009074) | 2.69533682 |
| 93 | plasma lipoprotein particle assembly (GO:0034377) | 2.69522818 |
| 94 | protein-lipid complex assembly (GO:0065005) | 2.68606627 |
| 95 | nitrogen cycle metabolic process (GO:0071941) | 2.67491840 |
| 96 | positive regulation of B cell differentiation (GO:0045579) | 2.67089139 |
| 97 | regulation of developmental pigmentation (GO:0048070) | 2.62517317 |
| 98 | negative regulation of mast cell activation (GO:0033004) | 2.62331161 |
| 99 | corticosteroid receptor signaling pathway (GO:0031958) | 2.61933603 |
| 100 | plasma lipoprotein particle clearance (GO:0034381) | 2.60367515 |
| 101 | serotonin metabolic process (GO:0042428) | 2.60186441 |
| 102 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.59121316 |
| 103 | regulation of gene silencing by miRNA (GO:0060964) | 2.59121316 |
| 104 | regulation of gene silencing by RNA (GO:0060966) | 2.59121316 |
| 105 | kynurenine metabolic process (GO:0070189) | 2.58899039 |
| 106 | low-density lipoprotein particle clearance (GO:0034383) | 2.58538114 |
| 107 | histone H3-K9 methylation (GO:0051567) | 2.58352564 |
| 108 | pigment cell differentiation (GO:0050931) | 2.57150369 |
| 109 | NAD biosynthetic process (GO:0009435) | 2.53439419 |
| 110 | apoptotic cell clearance (GO:0043277) | 2.52021723 |
| 111 | hormone catabolic process (GO:0042447) | 2.51469833 |
| 112 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.51341263 |
| 113 | intestinal cholesterol absorption (GO:0030299) | 2.51157442 |
| 114 | positive regulation of interferon-alpha production (GO:0032727) | 2.50564632 |
| 115 | endocardial cushion development (GO:0003197) | 2.50468639 |
| 116 | cholesterol efflux (GO:0033344) | 2.50381806 |
| 117 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.49843459 |
| 118 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.49843459 |
| 119 | modulation by symbiont of host immune response (GO:0052553) | 2.49843459 |
| 120 | positive regulation by symbiont of host defense response (GO:0052509) | 2.49843459 |
| 121 | modulation by symbiont of host defense response (GO:0052031) | 2.49843459 |
| 122 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.49843459 |
| 123 | tryptophan catabolic process (GO:0006569) | 2.48960799 |
| 124 | indole-containing compound catabolic process (GO:0042436) | 2.48960799 |
| 125 | indolalkylamine catabolic process (GO:0046218) | 2.48960799 |
| 126 | protein localization to lysosome (GO:0061462) | 2.47952195 |
| 127 | protein localization to vacuole (GO:0072665) | 2.47952195 |
| 128 | regulation of cholesterol storage (GO:0010885) | 2.47486620 |
| 129 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.46874732 |
| 130 | homocysteine metabolic process (GO:0050667) | 2.46866969 |
| 131 | amino-acid betaine metabolic process (GO:0006577) | 2.46099133 |
| 132 | protein localization to Golgi apparatus (GO:0034067) | 2.45810525 |
| 133 | plasma lipoprotein particle remodeling (GO:0034369) | 2.45109599 |
| 134 | protein-lipid complex remodeling (GO:0034368) | 2.45109599 |
| 135 | macromolecular complex remodeling (GO:0034367) | 2.45109599 |
| 136 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.44618385 |
| 137 | tryptophan metabolic process (GO:0006568) | 2.42949033 |
| 138 | microtubule anchoring (GO:0034453) | 2.42742139 |
| 139 | embryonic hemopoiesis (GO:0035162) | 2.42297193 |
| 140 | replicative senescence (GO:0090399) | 2.42024022 |
| 141 | primary amino compound metabolic process (GO:1901160) | 2.41773452 |
| 142 | cellular response to growth hormone stimulus (GO:0071378) | 2.41691122 |
| 143 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.41497705 |
| 144 | amine catabolic process (GO:0009310) | 2.41453141 |
| 145 | cellular biogenic amine catabolic process (GO:0042402) | 2.41453141 |
| 146 | lysine metabolic process (GO:0006553) | 2.41242303 |
| 147 | lysine catabolic process (GO:0006554) | 2.41242303 |
| 148 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.41030611 |
| 149 | primary alcohol catabolic process (GO:0034310) | 2.40464066 |
| 150 | positive regulation of lipid catabolic process (GO:0050996) | 2.40369575 |
| 151 | bile acid and bile salt transport (GO:0015721) | 2.40355218 |
| 152 | complement activation, classical pathway (GO:0006958) | 2.40020732 |
| 153 | melanocyte differentiation (GO:0030318) | 2.39863642 |
| 154 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.39106583 |
| 155 | positive regulation of histone deacetylation (GO:0031065) | 2.39001326 |
| 156 | cellular response to sterol (GO:0036315) | 2.38686312 |
| 157 | early endosome to late endosome transport (GO:0045022) | 2.38618829 |
| 158 | regulation of protein activation cascade (GO:2000257) | 2.38388196 |
| 159 | regulation of cholesterol esterification (GO:0010872) | 2.38340545 |
| 160 | cAMP catabolic process (GO:0006198) | 2.38075439 |
| 161 | lipoprotein metabolic process (GO:0042157) | 2.37825669 |
| 162 | transcytosis (GO:0045056) | 2.36822792 |
| 163 | reflex (GO:0060004) | 2.35906943 |
| 164 | macroautophagy (GO:0016236) | 2.35685402 |
| 165 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.35584247 |
| 166 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.35293698 |
| 167 | bile acid biosynthetic process (GO:0006699) | 2.35275712 |
| 168 | cholesterol homeostasis (GO:0042632) | 2.35177743 |
| 169 | regulation of interferon-alpha production (GO:0032647) | 2.35101142 |
| 170 | intestinal absorption (GO:0050892) | 2.34889331 |
| 171 | peptide catabolic process (GO:0043171) | 2.34834020 |
| 172 | sterol homeostasis (GO:0055092) | 2.34641466 |
| 173 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.34102612 |
| 174 | complement activation (GO:0006956) | 2.32627779 |
| 175 | rRNA catabolic process (GO:0016075) | 2.31964733 |
| 176 | behavioral response to ethanol (GO:0048149) | 2.31622594 |
| 177 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.30862115 |
| 178 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.30862115 |
| 179 | sulfation (GO:0051923) | 2.30839958 |
| 180 | appendage development (GO:0048736) | 2.30729110 |
| 181 | limb development (GO:0060173) | 2.30729110 |
| 182 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.30517733 |
| 183 | regulation of complement activation (GO:0030449) | 2.30435529 |
| 184 | striated muscle atrophy (GO:0014891) | 2.29912473 |
| 185 | cellular modified amino acid catabolic process (GO:0042219) | 2.29756976 |
| 186 | fatty acid oxidation (GO:0019395) | 2.29343074 |
| 187 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.28368180 |
| 188 | protein-lipid complex subunit organization (GO:0071825) | 2.27744282 |
| 189 | histone H3-K9 modification (GO:0061647) | 2.27692770 |
| 190 | macrophage activation involved in immune response (GO:0002281) | 2.27559156 |
| 191 | fatty acid beta-oxidation (GO:0006635) | 2.27226276 |
| 192 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.26621975 |
| 193 | neuron maturation (GO:0042551) | 2.26433958 |
| 194 | angiotensin maturation (GO:0002003) | 2.25951909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.95144869 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.68082850 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.54159062 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.52092919 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.45208767 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.20554246 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.19422341 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.92771641 |
| 9 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.87466652 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.75275738 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.69033452 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.66023410 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.62870750 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.55420085 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.46206356 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.38613188 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.36802896 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.36156740 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.35384980 |
| 20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.33243396 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.32736482 |
| 22 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30020989 |
| 23 | VDR_22108803_ChIP-Seq_LS180_Human | 2.23727082 |
| 24 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22910651 |
| 25 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.22196046 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.21178408 |
| 27 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.18297663 |
| 28 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.17650338 |
| 29 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.15271843 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.13772828 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.13122571 |
| 32 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.10668747 |
| 33 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.10380294 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.07927865 |
| 35 | TP53_16413492_ChIP-PET_HCT116_Human | 2.06026006 |
| 36 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.03255502 |
| 37 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.02983767 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01757801 |
| 39 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.98045546 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.93679121 |
| 41 | STAT3_23295773_ChIP-Seq_U87_Human | 1.90645846 |
| 42 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.89220551 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.84706242 |
| 44 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.84455971 |
| 45 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.84403166 |
| 46 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.84323842 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.83969465 |
| 48 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.83665372 |
| 49 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.82227714 |
| 50 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.81381965 |
| 51 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.81068307 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.80690360 |
| 53 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.80183536 |
| 54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.79882878 |
| 55 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.78847086 |
| 56 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.77605376 |
| 57 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.76339454 |
| 58 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75683410 |
| 59 | P300_19829295_ChIP-Seq_ESCs_Human | 1.74287438 |
| 60 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.73962417 |
| 61 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.72351881 |
| 62 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.71629112 |
| 63 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.71535876 |
| 64 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.69915626 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.67734384 |
| 66 | EWS_26573619_Chip-Seq_HEK293_Human | 1.65972480 |
| 67 | TCF4_23295773_ChIP-Seq_U87_Human | 1.62867778 |
| 68 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.62181325 |
| 69 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.61569934 |
| 70 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.58516626 |
| 71 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.58516626 |
| 72 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.58418416 |
| 73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57538871 |
| 74 | * MAF_26560356_Chip-Seq_TH1_Human | 1.56652355 |
| 75 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.56612069 |
| 76 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.53953568 |
| 77 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.53657124 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.53160238 |
| 79 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.53053323 |
| 80 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.51825676 |
| 81 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.51397838 |
| 82 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.51375317 |
| 83 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51257332 |
| 84 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50480073 |
| 85 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50216881 |
| 86 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.48860322 |
| 87 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.48323642 |
| 88 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.48191608 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.48041243 |
| 90 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.47411104 |
| 91 | MYC_22102868_ChIP-Seq_BL_Human | 1.47071392 |
| 92 | MYB_26560356_Chip-Seq_TH2_Human | 1.46555678 |
| 93 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.46517349 |
| 94 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.43845427 |
| 95 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43358286 |
| 96 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.42946861 |
| 97 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.41630056 |
| 98 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41276018 |
| 99 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39817011 |
| 100 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.39589187 |
| 101 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.39589187 |
| 102 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.38882335 |
| 103 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.37607638 |
| 104 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.37116681 |
| 105 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.37011894 |
| 106 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36271155 |
| 107 | MYB_26560356_Chip-Seq_TH1_Human | 1.34649042 |
| 108 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.33489979 |
| 109 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33240333 |
| 110 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33061076 |
| 111 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30522996 |
| 112 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.30449368 |
| 113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29461900 |
| 114 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29325939 |
| 115 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29078278 |
| 116 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28768288 |
| 117 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.28082507 |
| 118 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.27199580 |
| 119 | UTX_26944678_Chip-Seq_JUKART_Human | 1.25727209 |
| 120 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.25665634 |
| 121 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.25008858 |
| 122 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.24963180 |
| 123 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.24935243 |
| 124 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24922809 |
| 125 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24104031 |
| 126 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.23411203 |
| 127 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.23313841 |
| 128 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.23166541 |
| 129 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.22819249 |
| 130 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.21724130 |
| 131 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21636029 |
| 132 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.21630537 |
| 133 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.21112909 |
| 134 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20918028 |
| 135 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.20835094 |
| 136 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20742705 |
| 137 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20504966 |
| 138 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19843512 |
| 139 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.19269415 |
| 140 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19260987 |
| 141 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19260987 |
| 142 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.19163010 |
| 143 | SPI1_23127762_ChIP-Seq_K562_Human | 1.18216874 |
| 144 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.17119874 |
| 145 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16781192 |
| 146 | RXR_22108803_ChIP-Seq_LS180_Human | 1.16349419 |
| 147 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.15545978 |
| 148 | GATA2_19941826_ChIP-Seq_K562_Human | 1.15402951 |
| 149 | CJUN_26792858_Chip-Seq_BT549_Human | 1.15398805 |
| 150 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15027282 |
| 151 | KDM2B_26808549_Chip-Seq_REH_Human | 1.13671627 |
| 152 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.13603537 |
| 153 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12910468 |
| 154 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.12803422 |
| 155 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12783677 |
| 156 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.12526937 |
| 157 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12313353 |
| 158 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12065826 |
| 159 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11986642 |
| 160 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11481222 |
| 161 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.10478605 |
| 162 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.10218553 |
| 163 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09620494 |
| 164 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.09011544 |
| 165 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.08874649 |
| 166 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08253453 |
| 167 | * CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.06926633 |
| 168 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05766966 |
| 169 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05706811 |
| 170 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.05451807 |
| 171 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05313599 |
| 172 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.05228585 |
| 173 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05181601 |
| 174 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04845280 |
| 175 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.04769075 |
| 176 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.04532769 |
| 177 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.04532769 |
| 178 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04408722 |
| 179 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04314353 |
| 180 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03932338 |
| 181 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03840617 |
| 182 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03297677 |
| 183 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.03129884 |
| 184 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02955617 |
| 185 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.02613589 |
| 186 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02565509 |
| 187 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.02542925 |
| 188 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02173558 |
| 189 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01831756 |
| 190 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01372181 |
| 191 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01056905 |
| 192 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.00826459 |
| 193 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.00820233 |
| 194 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.99911685 |
| 195 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98590425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 7.74200769 |
| 2 | MP0008057_abnormal_DNA_replication | 4.79920139 |
| 3 | MP0003195_calcinosis | 4.03252185 |
| 4 | MP0005360_urolithiasis | 3.63888060 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.53676180 |
| 6 | MP0003787_abnormal_imprinting | 2.86206964 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.85670700 |
| 8 | MP0000427_abnormal_hair_cycle | 2.83962602 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 2.78851909 |
| 10 | MP0003646_muscle_fatigue | 2.67250018 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.65069259 |
| 12 | MP0009840_abnormal_foam_cell | 2.60236008 |
| 13 | MP0005174_abnormal_tail_pigmentation | 2.60044863 |
| 14 | MP0005365_abnormal_bile_salt | 2.56670610 |
| 15 | MP0005085_abnormal_gallbladder_physiolo | 2.53357280 |
| 16 | MP0004043_abnormal_pH_regulation | 2.51015477 |
| 17 | MP0003890_abnormal_embryonic-extraembry | 2.47414493 |
| 18 | MP0000383_abnormal_hair_follicle | 2.40754750 |
| 19 | MP0008961_abnormal_basal_metabolism | 2.32909585 |
| 20 | MP0003252_abnormal_bile_duct | 2.22514403 |
| 21 | MP0008875_abnormal_xenobiotic_pharmacok | 2.20798334 |
| 22 | MP0005058_abnormal_lysosome_morphology | 2.19925141 |
| 23 | MP0002009_preneoplasia | 2.19781391 |
| 24 | MP0001835_abnormal_antigen_presentation | 2.17500496 |
| 25 | MP0001666_abnormal_nutrient_absorption | 2.07539507 |
| 26 | MP0009046_muscle_twitch | 2.01739328 |
| 27 | MP0010329_abnormal_lipoprotein_level | 2.01134632 |
| 28 | MP0003436_decreased_susceptibility_to | 1.97751239 |
| 29 | MP0002166_altered_tumor_susceptibility | 1.97211356 |
| 30 | MP0000015_abnormal_ear_pigmentation | 1.95444694 |
| 31 | MP0000685_abnormal_immune_system | 1.89351556 |
| 32 | MP0008877_abnormal_DNA_methylation | 1.89311539 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.78151291 |
| 34 | MP0004947_skin_inflammation | 1.77920777 |
| 35 | MP0005551_abnormal_eye_electrophysiolog | 1.75704337 |
| 36 | MP0006082_CNS_inflammation | 1.73046333 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.70903773 |
| 38 | MP0001501_abnormal_sleep_pattern | 1.69139632 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.68637805 |
| 40 | MP0001873_stomach_inflammation | 1.66745929 |
| 41 | MP0002928_abnormal_bile_duct | 1.66590090 |
| 42 | MP0000371_diluted_coat_color | 1.66168673 |
| 43 | MP0002254_reproductive_system_inflammat | 1.65381281 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.62474395 |
| 45 | MP0002095_abnormal_skin_pigmentation | 1.61926288 |
| 46 | MP0003303_peritoneal_inflammation | 1.57858969 |
| 47 | MP0000609_abnormal_liver_physiology | 1.55176766 |
| 48 | MP0002419_abnormal_innate_immunity | 1.53173440 |
| 49 | MP0001790_abnormal_immune_system | 1.50396116 |
| 50 | MP0005387_immune_system_phenotype | 1.50396116 |
| 51 | MP0001800_abnormal_humoral_immune | 1.49466478 |
| 52 | MP0002168_other_aberrant_phenotype | 1.49464462 |
| 53 | MP0004264_abnormal_extraembryonic_tissu | 1.49034898 |
| 54 | MP0009785_altered_susceptibility_to | 1.48692885 |
| 55 | MP0005025_abnormal_response_to | 1.48223681 |
| 56 | MP0004142_abnormal_muscle_tone | 1.45241101 |
| 57 | MP0003950_abnormal_plasma_membrane | 1.42612972 |
| 58 | MP0003724_increased_susceptibility_to | 1.41869512 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.40377143 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.38643278 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.37645768 |
| 62 | MP0006054_spinal_hemorrhage | 1.37301992 |
| 63 | MP0003566_abnormal_cell_adhesion | 1.35472368 |
| 64 | MP0005671_abnormal_response_to | 1.34628062 |
| 65 | MP0009643_abnormal_urine_homeostasis | 1.33607690 |
| 66 | MP0004924_abnormal_behavior | 1.33384009 |
| 67 | MP0005386_behavior/neurological_phenoty | 1.33384009 |
| 68 | MP0010386_abnormal_urinary_bladder | 1.32708357 |
| 69 | MP0002006_tumorigenesis | 1.31836381 |
| 70 | MP0002796_impaired_skin_barrier | 1.30642114 |
| 71 | MP0005000_abnormal_immune_tolerance | 1.29355003 |
| 72 | MP0004381_abnormal_hair_follicle | 1.28631655 |
| 73 | MP0001845_abnormal_inflammatory_respons | 1.28216971 |
| 74 | MP0002723_abnormal_immune_serum | 1.26012078 |
| 75 | MP0005332_abnormal_amino_acid | 1.25762458 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 1.25147150 |
| 77 | MP0008469_abnormal_protein_level | 1.23018847 |
| 78 | MP0002118_abnormal_lipid_homeostasis | 1.22240804 |
| 79 | MP0001485_abnormal_pinna_reflex | 1.21951834 |
| 80 | MP0001533_abnormal_skeleton_physiology | 1.20570599 |
| 81 | MP0009115_abnormal_fat_cell | 1.19536037 |
| 82 | MP0001819_abnormal_immune_cell | 1.18576571 |
| 83 | MP0002420_abnormal_adaptive_immunity | 1.17950876 |
| 84 | MP0002148_abnormal_hypersensitivity_rea | 1.17889958 |
| 85 | MP0009764_decreased_sensitivity_to | 1.17451232 |
| 86 | MP0003806_abnormal_nucleotide_metabolis | 1.15936547 |
| 87 | MP0004019_abnormal_vitamin_homeostasis | 1.15450129 |
| 88 | MP0001853_heart_inflammation | 1.15310315 |
| 89 | MP0003866_abnormal_defecation | 1.14866045 |
| 90 | MP0002837_dystrophic_cardiac_calcinosis | 1.12965504 |
| 91 | MP0005310_abnormal_salivary_gland | 1.12287831 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 1.11220187 |
| 93 | MP0003183_abnormal_peptide_metabolism | 1.10656112 |
| 94 | MP0010352_gastrointestinal_tract_polyps | 1.09958039 |
| 95 | MP0005171_absent_coat_pigmentation | 1.09524718 |
| 96 | MP0005266_abnormal_metabolism | 1.09259905 |
| 97 | MP0000470_abnormal_stomach_morphology | 1.08280896 |
| 98 | MP0005083_abnormal_biliary_tract | 1.07237812 |
| 99 | MP0003075_altered_response_to | 1.06074645 |
| 100 | MP0003690_abnormal_glial_cell | 1.05703350 |
| 101 | MP0010678_abnormal_skin_adnexa | 1.04881972 |
| 102 | MP0002136_abnormal_kidney_physiology | 1.04075834 |
| 103 | MP0004130_abnormal_muscle_cell | 1.03132415 |
| 104 | MP0002405_respiratory_system_inflammati | 1.03116786 |
| 105 | MP0009745_abnormal_behavioral_response | 1.02840457 |
| 106 | MP0005646_abnormal_pituitary_gland | 1.02698474 |
| 107 | MP0003172_abnormal_lysosome_physiology | 1.02042978 |
| 108 | MP0000631_abnormal_neuroendocrine_gland | 1.00576038 |
| 109 | MP0004185_abnormal_adipocyte_glucose | 1.00434422 |
| 110 | MP0001324_abnormal_eye_pigmentation | 1.00266579 |
| 111 | MP0000372_irregular_coat_pigmentation | 0.98938920 |
| 112 | MP0000604_amyloidosis | 0.98757017 |
| 113 | MP0005166_decreased_susceptibility_to | 0.98626527 |
| 114 | MP0001968_abnormal_touch/_nociception | 0.98043926 |
| 115 | MP0000230_abnormal_systemic_arterial | 0.97594107 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97451269 |
| 117 | MP0002396_abnormal_hematopoietic_system | 0.97119594 |
| 118 | MP0005023_abnormal_wound_healing | 0.96377707 |
| 119 | MP0009278_abnormal_bone_marrow | 0.96038904 |
| 120 | MP0005253_abnormal_eye_physiology | 0.95260258 |
| 121 | MP0005448_abnormal_energy_balance | 0.94727269 |
| 122 | MP0001216_abnormal_epidermal_layer | 0.93241636 |
| 123 | MP0005167_abnormal_blood-brain_barrier | 0.93112452 |
| 124 | MP0000716_abnormal_immune_system | 0.92516804 |
| 125 | MP0002067_abnormal_sensory_capabilities | 0.92237263 |
| 126 | MP0005075_abnormal_melanosome_morpholog | 0.91837016 |
| 127 | MP0002060_abnormal_skin_morphology | 0.91573094 |
| 128 | MP0005645_abnormal_hypothalamus_physiol | 0.91261549 |
| 129 | MP0000598_abnormal_liver_morphology | 0.90798750 |
| 130 | MP0003632_abnormal_nervous_system | 0.90134520 |
| 131 | MP0003045_fibrosis | 0.89931313 |
| 132 | MP0000538_abnormal_urinary_bladder | 0.88760017 |
| 133 | MP0003136_yellow_coat_color | 0.88528131 |
| 134 | MP0003763_abnormal_thymus_physiology | 0.88127673 |
| 135 | MP0005647_abnormal_sex_gland | 0.87558610 |
| 136 | MP0009763_increased_sensitivity_to | 0.86756414 |
| 137 | MP0000689_abnormal_spleen_morphology | 0.86061875 |
| 138 | MP0002638_abnormal_pupillary_reflex | 0.84926077 |
| 139 | MP0002398_abnormal_bone_marrow | 0.84882577 |
| 140 | MP0002102_abnormal_ear_morphology | 0.84674585 |
| 141 | MP0003633_abnormal_nervous_system | 0.84084737 |
| 142 | MP0001986_abnormal_taste_sensitivity | 0.83846794 |
| 143 | MP0005666_abnormal_adipose_tissue | 0.83389742 |
| 144 | MP0003656_abnormal_erythrocyte_physiolo | 0.82891388 |
| 145 | MP0000647_abnormal_sebaceous_gland | 0.82869240 |
| 146 | MP0000858_altered_metastatic_potential | 0.82467140 |
| 147 | MP0002557_abnormal_social/conspecific_i | 0.81556611 |
| 148 | MP0000343_altered_response_to | 0.81079244 |
| 149 | MP0000778_abnormal_nervous_system | 0.80406950 |
| 150 | MP0001851_eye_inflammation | 0.79400607 |
| 151 | MP0002075_abnormal_coat/hair_pigmentati | 0.77637491 |
| 152 | MP0002722_abnormal_immune_system | 0.77298392 |
| 153 | MP0001756_abnormal_urination | 0.77296837 |
| 154 | MP0003943_abnormal_hepatobiliary_system | 0.77161138 |
| 155 | MP0002429_abnormal_blood_cell | 0.76537069 |
| 156 | MP0005408_hypopigmentation | 0.76495666 |
| 157 | MP0000249_abnormal_blood_vessel | 0.75941219 |
| 158 | MP0004885_abnormal_endolymph | 0.74623206 |
| 159 | MP0002693_abnormal_pancreas_physiology | 0.73722224 |
| 160 | MP0002064_seizures | 0.72923157 |
| 161 | MP0003631_nervous_system_phenotype | 0.72865600 |
| 162 | MP0002938_white_spotting | 0.72700817 |
| 163 | MP0002572_abnormal_emotion/affect_behav | 0.72698643 |
| 164 | MP0001663_abnormal_digestive_system | 0.72399379 |
| 165 | MP0002272_abnormal_nervous_system | 0.72232847 |
| 166 | MP0002933_joint_inflammation | 0.72015748 |
| 167 | MP0002998_abnormal_bone_remodeling | 0.71519943 |
| 168 | MP0006276_abnormal_autonomic_nervous | 0.71137797 |
| 169 | MP0005195_abnormal_posterior_eye | 0.69798870 |
| 170 | MP0008872_abnormal_physiological_respon | 0.69233833 |
| 171 | MP0002735_abnormal_chemical_nociception | 0.68537726 |
| 172 | MP0001486_abnormal_startle_reflex | 0.68032829 |
| 173 | MP0002332_abnormal_exercise_endurance | 0.66554895 |
| 174 | MP0005395_other_phenotype | 0.66442770 |
| 175 | MP0001970_abnormal_pain_threshold | 0.65519656 |
| 176 | MP0003868_abnormal_feces_composition | 0.63292640 |
| 177 | MP0002109_abnormal_limb_morphology | 0.63164895 |
| 178 | MP0002229_neurodegeneration | 0.62230657 |
| 179 | MP0004134_abnormal_chest_morphology | 0.60846366 |
| 180 | MP0002909_abnormal_adrenal_gland | 0.58696936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Genetic anticipation (HP:0003743) | 5.64863278 |
| 2 | Hyperventilation (HP:0002883) | 4.81101597 |
| 3 | Protruding tongue (HP:0010808) | 4.53427173 |
| 4 | Pancreatic cysts (HP:0001737) | 4.13152560 |
| 5 | Progressive cerebellar ataxia (HP:0002073) | 3.86915973 |
| 6 | Complement deficiency (HP:0004431) | 3.80475200 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 3.79854231 |
| 8 | Gaze-evoked nystagmus (HP:0000640) | 3.67968053 |
| 9 | Deep venous thrombosis (HP:0002625) | 3.46641271 |
| 10 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.46091471 |
| 11 | Pancreatic fibrosis (HP:0100732) | 3.45499363 |
| 12 | Fair hair (HP:0002286) | 3.43230839 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 3.41836921 |
| 14 | Xanthomatosis (HP:0000991) | 3.36857216 |
| 15 | Clumsiness (HP:0002312) | 3.17667809 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 3.16537601 |
| 17 | True hermaphroditism (HP:0010459) | 3.15920937 |
| 18 | Abnormality of midbrain morphology (HP:0002418) | 3.08962400 |
| 19 | Molar tooth sign on MRI (HP:0002419) | 3.08962400 |
| 20 | Eczematoid dermatitis (HP:0000976) | 3.05702315 |
| 21 | Myocardial infarction (HP:0001658) | 3.05561374 |
| 22 | Glomerulonephritis (HP:0000099) | 3.04413399 |
| 23 | Abnormality of the renal cortex (HP:0011035) | 2.99880175 |
| 24 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.99244176 |
| 25 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.96935772 |
| 26 | Abnormality of complement system (HP:0005339) | 2.96072697 |
| 27 | Chronic hepatic failure (HP:0100626) | 2.93465494 |
| 28 | Generalized hypopigmentation of hair (HP:0011358) | 2.89061181 |
| 29 | Interstitial pulmonary disease (HP:0006530) | 2.88523077 |
| 30 | Nephronophthisis (HP:0000090) | 2.87706722 |
| 31 | Widely spaced teeth (HP:0000687) | 2.85471611 |
| 32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.84846046 |
| 33 | Abnormality of the renal medulla (HP:0100957) | 2.84484265 |
| 34 | Increased cerebral lipofuscin (HP:0011813) | 2.77759250 |
| 35 | Hematochezia (HP:0002573) | 2.76398029 |
| 36 | Tubular atrophy (HP:0000092) | 2.70459131 |
| 37 | Dysostosis multiplex (HP:0000943) | 2.67559900 |
| 38 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.67501080 |
| 39 | Colitis (HP:0002583) | 2.65904766 |
| 40 | Recurrent bacterial skin infections (HP:0005406) | 2.65406762 |
| 41 | Autoimmune thrombocytopenia (HP:0001973) | 2.65039828 |
| 42 | Esophageal varix (HP:0002040) | 2.63545579 |
| 43 | Mucopolysacchariduria (HP:0008155) | 2.62111376 |
| 44 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.62111376 |
| 45 | Cystic liver disease (HP:0006706) | 2.59894924 |
| 46 | Abnormality of the common coagulation pathway (HP:0010990) | 2.59723074 |
| 47 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.59060216 |
| 48 | Hypoplastic labia majora (HP:0000059) | 2.56521527 |
| 49 | Hypobetalipoproteinemia (HP:0003563) | 2.55405305 |
| 50 | Nephritis (HP:0000123) | 2.54309939 |
| 51 | Spontaneous hematomas (HP:0007420) | 2.53839811 |
| 52 | Abnormality of the axillary hair (HP:0100134) | 2.53718088 |
| 53 | Abnormality of secondary sexual hair (HP:0009888) | 2.53718088 |
| 54 | Hypoplastic ischia (HP:0003175) | 2.51848104 |
| 55 | Recurrent abscess formation (HP:0002722) | 2.51134168 |
| 56 | Joint hemorrhage (HP:0005261) | 2.50740360 |
| 57 | Congenital stationary night blindness (HP:0007642) | 2.48616304 |
| 58 | Hyperlipoproteinemia (HP:0010980) | 2.46313858 |
| 59 | Aortic aneurysm (HP:0004942) | 2.46296591 |
| 60 | Dysmetric saccades (HP:0000641) | 2.45657625 |
| 61 | Right ventricular cardiomyopathy (HP:0011663) | 2.43326743 |
| 62 | Abnormality of the ischium (HP:0003174) | 2.42926942 |
| 63 | Recurrent viral infections (HP:0004429) | 2.40096983 |
| 64 | Pustule (HP:0200039) | 2.37566884 |
| 65 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.37562591 |
| 66 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.37562591 |
| 67 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.37562591 |
| 68 | Broad-based gait (HP:0002136) | 2.37278432 |
| 69 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.37277762 |
| 70 | Febrile seizures (HP:0002373) | 2.36717780 |
| 71 | Fat malabsorption (HP:0002630) | 2.35712735 |
| 72 | Abnormality of the labia majora (HP:0012881) | 2.35321796 |
| 73 | Inflammation of the large intestine (HP:0002037) | 2.34160365 |
| 74 | Decreased circulating renin level (HP:0003351) | 2.33296223 |
| 75 | Abnormality of proline metabolism (HP:0010907) | 2.29999313 |
| 76 | Hydroxyprolinuria (HP:0003080) | 2.29999313 |
| 77 | Truncal obesity (HP:0001956) | 2.27745572 |
| 78 | Recurrent fungal infections (HP:0002841) | 2.27587464 |
| 79 | Medial flaring of the eyebrow (HP:0010747) | 2.25438651 |
| 80 | Attenuation of retinal blood vessels (HP:0007843) | 2.24193135 |
| 81 | Furrowed tongue (HP:0000221) | 2.23703994 |
| 82 | Gingival bleeding (HP:0000225) | 2.23412568 |
| 83 | Absent speech (HP:0001344) | 2.22823296 |
| 84 | Hyperammonemia (HP:0001987) | 2.22395009 |
| 85 | Gastrointestinal inflammation (HP:0004386) | 2.22376941 |
| 86 | Osteolytic defects of the hand bones (HP:0009699) | 2.22000479 |
| 87 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.22000479 |
| 88 | Myositis (HP:0100614) | 2.21939090 |
| 89 | Cellulitis (HP:0100658) | 2.21697860 |
| 90 | Abnormal platelet function (HP:0011869) | 2.20986616 |
| 91 | Impaired platelet aggregation (HP:0003540) | 2.20986616 |
| 92 | Volvulus (HP:0002580) | 2.20952245 |
| 93 | Periodontitis (HP:0000704) | 2.20302183 |
| 94 | Amyloidosis (HP:0011034) | 2.19551410 |
| 95 | Hypercholesterolemia (HP:0003124) | 2.18356936 |
| 96 | Chronic otitis media (HP:0000389) | 2.17869010 |
| 97 | Congenital sensorineural hearing impairment (HP:0008527) | 2.17076051 |
| 98 | Hemorrhage of the eye (HP:0011885) | 2.16631131 |
| 99 | Increased IgE level (HP:0003212) | 2.14658069 |
| 100 | Hypolipoproteinemia (HP:0010981) | 2.14638366 |
| 101 | Blue irides (HP:0000635) | 2.14418842 |
| 102 | Abnormality of the intrinsic pathway (HP:0010989) | 2.14311474 |
| 103 | Macroglossia (HP:0000158) | 2.13360206 |
| 104 | Vascular calcification (HP:0004934) | 2.13027096 |
| 105 | Prolonged partial thromboplastin time (HP:0003645) | 2.13020894 |
| 106 | Abnormality of macrophages (HP:0004311) | 2.12556382 |
| 107 | Drooling (HP:0002307) | 2.11992462 |
| 108 | Poor coordination (HP:0002370) | 2.10851430 |
| 109 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.09493805 |
| 110 | Epidermoid cyst (HP:0200040) | 2.09236500 |
| 111 | Abnormal platelet volume (HP:0011876) | 2.04667348 |
| 112 | Thrombocytosis (HP:0001894) | 2.03783236 |
| 113 | Large for gestational age (HP:0001520) | 2.02918031 |
| 114 | Increased mean platelet volume (HP:0011877) | 2.02286462 |
| 115 | Abnormality of the nasal mucosa (HP:0000433) | 2.01836365 |
| 116 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.01519215 |
| 117 | Hypoalphalipoproteinemia (HP:0003233) | 2.01501064 |
| 118 | Patellar aplasia (HP:0006443) | 2.01152278 |
| 119 | Congenital hepatic fibrosis (HP:0002612) | 2.00293246 |
| 120 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.00226612 |
| 121 | Axonal loss (HP:0003447) | 1.99980982 |
| 122 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.99579120 |
| 123 | Recurrent skin infections (HP:0001581) | 1.99006570 |
| 124 | Birth length less than 3rd percentile (HP:0003561) | 1.98676098 |
| 125 | Arterial thrombosis (HP:0004420) | 1.98445518 |
| 126 | Polycythemia (HP:0001901) | 1.97859518 |
| 127 | Chronic diarrhea (HP:0002028) | 1.97841171 |
| 128 | Excessive salivation (HP:0003781) | 1.97442651 |
| 129 | Inability to walk (HP:0002540) | 1.96867897 |
| 130 | Acute myeloid leukemia (HP:0004808) | 1.95988844 |
| 131 | Hyperglycinuria (HP:0003108) | 1.95670541 |
| 132 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.95622787 |
| 133 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.95497909 |
| 134 | Abnormality of the nasal septum (HP:0000419) | 1.94968327 |
| 135 | Gait imbalance (HP:0002141) | 1.94437330 |
| 136 | Ketosis (HP:0001946) | 1.93972723 |
| 137 | Cardiovascular calcification (HP:0011915) | 1.92486784 |
| 138 | Fatigue (HP:0012378) | 1.90984668 |
| 139 | Cerebral aneurysm (HP:0004944) | 1.90964536 |
| 140 | Polydipsia (HP:0001959) | 1.90389081 |
| 141 | Abnormal drinking behavior (HP:0030082) | 1.90389081 |
| 142 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.90354629 |
| 143 | Highly arched eyebrow (HP:0002553) | 1.90222119 |
| 144 | Congenital primary aphakia (HP:0007707) | 1.89996916 |
| 145 | Tapered finger (HP:0001182) | 1.87890037 |
| 146 | Nasal polyposis (HP:0100582) | 1.87540558 |
| 147 | Orchitis (HP:0100796) | 1.86098629 |
| 148 | IgM deficiency (HP:0002850) | 1.85558039 |
| 149 | Short chin (HP:0000331) | 1.85197081 |
| 150 | Increased number of teeth (HP:0011069) | 1.85005972 |
| 151 | Epistaxis (HP:0000421) | 1.84759593 |
| 152 | Short foot (HP:0001773) | 1.84461794 |
| 153 | Thick eyebrow (HP:0000574) | 1.84163665 |
| 154 | Abnormality of purine metabolism (HP:0004352) | 1.84097158 |
| 155 | Osteomyelitis (HP:0002754) | 1.83799190 |
| 156 | Pulmonary embolism (HP:0002204) | 1.83788949 |
| 157 | Malnutrition (HP:0004395) | 1.83655632 |
| 158 | Menorrhagia (HP:0000132) | 1.83225900 |
| 159 | Mitral stenosis (HP:0001718) | 1.83021814 |
| 160 | Progressive inability to walk (HP:0002505) | 1.82963166 |
| 161 | Oligodactyly (hands) (HP:0001180) | 1.81421365 |
| 162 | Clubbing of toes (HP:0100760) | 1.80221207 |
| 163 | Cardiomegaly (HP:0001640) | 1.80002937 |
| 164 | Steatorrhea (HP:0002570) | 1.79553152 |
| 165 | Hypoplastic iliac wings (HP:0002866) | 1.79403328 |
| 166 | Bulbous nose (HP:0000414) | 1.79007214 |
| 167 | Absent/shortened dynein arms (HP:0200106) | 1.78006663 |
| 168 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.78006663 |
| 169 | Conjugated hyperbilirubinemia (HP:0002908) | 1.77952371 |
| 170 | Hepatocellular carcinoma (HP:0001402) | 1.77218626 |
| 171 | Focal segmental glomerulosclerosis (HP:0000097) | 1.77203566 |
| 172 | Tented upper lip vermilion (HP:0010804) | 1.76937276 |
| 173 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.75902018 |
| 174 | Genital tract atresia (HP:0001827) | 1.74832866 |
| 175 | Stomach cancer (HP:0012126) | 1.74769955 |
| 176 | Narrow palate (HP:0000189) | 1.71543747 |
| 177 | Preaxial foot polydactyly (HP:0001841) | 1.70520868 |
| 178 | Acute lymphatic leukemia (HP:0006721) | 1.70435400 |
| 179 | Impaired smooth pursuit (HP:0007772) | 1.69649692 |
| 180 | Nephrogenic diabetes insipidus (HP:0009806) | 1.69311039 |
| 181 | Exotropia (HP:0000577) | 1.67152082 |
| 182 | Vaginal atresia (HP:0000148) | 1.66727640 |
| 183 | Inappropriate behavior (HP:0000719) | 1.65503829 |
| 184 | Abnormality of incisor morphology (HP:0011063) | 1.64950494 |
| 185 | Abolished electroretinogram (ERG) (HP:0000550) | 1.64508800 |
| 186 | Renal cortical cysts (HP:0000803) | 1.62493617 |
| 187 | Wide intermamillary distance (HP:0006610) | 1.62398746 |
| 188 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.59188973 |
| 189 | Intellectual disability, progressive (HP:0006887) | 1.57709267 |
| 190 | Tracheomalacia (HP:0002779) | 1.56455954 |
| 191 | Prominent nose (HP:0000448) | 1.55846486 |
| 192 | Macroorchidism (HP:0000053) | 1.55521457 |
| 193 | Oligodontia (HP:0000677) | 1.55283518 |
| 194 | Thyroiditis (HP:0100646) | 1.55088023 |
| 195 | Lip pit (HP:0100267) | 1.54658496 |
| 196 | Hyperkalemia (HP:0002153) | 1.54057701 |
| 197 | Macular degeneration (HP:0000608) | 1.53636621 |
| 198 | Anencephaly (HP:0002323) | 1.52768898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 4.08682936 |
| 2 | ERN1 | 3.72277116 |
| 3 | BMPR1B | 3.16598346 |
| 4 | TRIB3 | 2.96415923 |
| 5 | TGFBR2 | 2.73726929 |
| 6 | EEF2K | 2.48617259 |
| 7 | TAOK3 | 2.47146185 |
| 8 | TYK2 | 2.46238086 |
| 9 | AKT3 | 2.37231686 |
| 10 | PKN2 | 2.36293617 |
| 11 | MAP4K1 | 2.24843410 |
| 12 | FGFR4 | 2.12328361 |
| 13 | EPHB1 | 2.12325189 |
| 14 | SIK1 | 2.10977724 |
| 15 | PTK6 | 2.09844104 |
| 16 | STK10 | 2.01272992 |
| 17 | CASK | 1.90340246 |
| 18 | FRK | 1.84979830 |
| 19 | LRRK2 | 1.84682639 |
| 20 | MKNK2 | 1.81406115 |
| 21 | ADRBK2 | 1.79935958 |
| 22 | RIPK1 | 1.78618140 |
| 23 | MAP3K10 | 1.76730560 |
| 24 | MST4 | 1.74556132 |
| 25 | JAK3 | 1.73697150 |
| 26 | TBK1 | 1.71614866 |
| 27 | JAK1 | 1.67332392 |
| 28 | MST1R | 1.56653372 |
| 29 | CSF1R | 1.52352093 |
| 30 | BCKDK | 1.50183273 |
| 31 | MAP2K3 | 1.49533715 |
| 32 | FLT3 | 1.47893342 |
| 33 | MAP3K14 | 1.41765661 |
| 34 | INSRR | 1.41604430 |
| 35 | SGK2 | 1.39619186 |
| 36 | ZAP70 | 1.39405720 |
| 37 | FGFR3 | 1.33165953 |
| 38 | BTK | 1.32256571 |
| 39 | OXSR1 | 1.27771583 |
| 40 | GRK1 | 1.26345078 |
| 41 | ITK | 1.24829134 |
| 42 | IRAK3 | 1.23275470 |
| 43 | LMTK2 | 1.22234988 |
| 44 | CAMK1D | 1.21982082 |
| 45 | TNIK | 1.20802040 |
| 46 | BLK | 1.20469267 |
| 47 | CSK | 1.19589810 |
| 48 | EPHA2 | 1.18508678 |
| 49 | CDK12 | 1.18391948 |
| 50 | ADRBK1 | 1.17980889 |
| 51 | IKBKE | 1.16726357 |
| 52 | NEK9 | 1.16424860 |
| 53 | KIT | 1.15769281 |
| 54 | JAK2 | 1.13824374 |
| 55 | MELK | 1.12783223 |
| 56 | WNK3 | 1.12336445 |
| 57 | GRK6 | 1.10523982 |
| 58 | MAP3K4 | 1.09364646 |
| 59 | PIK3CA | 1.09137137 |
| 60 | CDK6 | 1.08881192 |
| 61 | CAMKK2 | 1.08739355 |
| 62 | TRPM7 | 1.05968320 |
| 63 | MAPK13 | 1.05559899 |
| 64 | TTN | 1.04793196 |
| 65 | MAPKAPK3 | 1.03389577 |
| 66 | PIK3CG | 1.01495180 |
| 67 | STK38L | 1.00879161 |
| 68 | WNK1 | 0.97194464 |
| 69 | NTRK3 | 0.94225719 |
| 70 | IRAK4 | 0.94097027 |
| 71 | MAP3K3 | 0.92918304 |
| 72 | LATS1 | 0.91083865 |
| 73 | PAK4 | 0.90639561 |
| 74 | MAP3K7 | 0.89770173 |
| 75 | IKBKB | 0.88367189 |
| 76 | SIK2 | 0.87733325 |
| 77 | WNK4 | 0.86883050 |
| 78 | MAP3K2 | 0.86113575 |
| 79 | PAK3 | 0.85720108 |
| 80 | MAPK15 | 0.85672379 |
| 81 | HCK | 0.83999006 |
| 82 | SGK3 | 0.82434562 |
| 83 | PNCK | 0.81202190 |
| 84 | SGK494 | 0.80361171 |
| 85 | SGK223 | 0.80361171 |
| 86 | KDR | 0.78251928 |
| 87 | DAPK2 | 0.76603485 |
| 88 | MAP2K2 | 0.76012808 |
| 89 | BRD4 | 0.75941474 |
| 90 | STK3 | 0.75886425 |
| 91 | RPS6KB2 | 0.75846938 |
| 92 | LCK | 0.74244529 |
| 93 | CAMK1G | 0.72287290 |
| 94 | ZAK | 0.72002690 |
| 95 | TEC | 0.70641460 |
| 96 | SYK | 0.69782742 |
| 97 | EPHA3 | 0.68830711 |
| 98 | MAPK11 | 0.68016609 |
| 99 | PTK2B | 0.68000906 |
| 100 | MARK3 | 0.67776281 |
| 101 | CHUK | 0.67248185 |
| 102 | SCYL2 | 0.66100619 |
| 103 | MAP3K13 | 0.65629995 |
| 104 | STK11 | 0.64826647 |
| 105 | IRAK1 | 0.64405783 |
| 106 | NUAK1 | 0.64120029 |
| 107 | TIE1 | 0.63995729 |
| 108 | STK38 | 0.63916626 |
| 109 | MET | 0.63756604 |
| 110 | TLK1 | 0.62576255 |
| 111 | TGFBR1 | 0.62173629 |
| 112 | MATK | 0.61554776 |
| 113 | SGK1 | 0.61303599 |
| 114 | ERBB2 | 0.61118395 |
| 115 | STK39 | 0.58031649 |
| 116 | BMX | 0.57384436 |
| 117 | PDGFRB | 0.56546027 |
| 118 | PRKCE | 0.56442700 |
| 119 | STK24 | 0.56135321 |
| 120 | PRKAA2 | 0.55786364 |
| 121 | CDC42BPA | 0.55733832 |
| 122 | DMPK | 0.55277916 |
| 123 | FGFR2 | 0.54435706 |
| 124 | RET | 0.53370432 |
| 125 | RIPK4 | 0.53155354 |
| 126 | PTK2 | 0.52687168 |
| 127 | PRKG2 | 0.52632974 |
| 128 | DYRK1B | 0.52303289 |
| 129 | PRKCH | 0.51973521 |
| 130 | CAMK4 | 0.51407075 |
| 131 | RPS6KA6 | 0.51143516 |
| 132 | FER | 0.49552984 |
| 133 | MKNK1 | 0.49516741 |
| 134 | PRKAA1 | 0.49350111 |
| 135 | EGFR | 0.49199449 |
| 136 | TXK | 0.48969478 |
| 137 | GSK3A | 0.47863638 |
| 138 | PDK1 | 0.47733327 |
| 139 | CDK9 | 0.47159743 |
| 140 | PAK2 | 0.47020996 |
| 141 | LYN | 0.47017961 |
| 142 | PIM1 | 0.46771595 |
| 143 | MAP3K8 | 0.45922199 |
| 144 | STK4 | 0.45173762 |
| 145 | PRKCQ | 0.44526302 |
| 146 | PDGFRA | 0.44446527 |
| 147 | PRKD1 | 0.44283770 |
| 148 | GRK7 | 0.44268713 |
| 149 | PDPK1 | 0.43172109 |
| 150 | NLK | 0.42709938 |
| 151 | MARK2 | 0.41917539 |
| 152 | BRSK2 | 0.41512478 |
| 153 | PINK1 | 0.40120801 |
| 154 | MAPK7 | 0.39251587 |
| 155 | CAMK1 | 0.37255440 |
| 156 | MAP4K2 | 0.37064735 |
| 157 | PKN1 | 0.34956715 |
| 158 | ABL1 | 0.33249764 |
| 159 | CSNK1D | 0.32153059 |
| 160 | MTOR | 0.31437847 |
| 161 | HIPK2 | 0.30906472 |
| 162 | MAP2K6 | 0.30609798 |
| 163 | PRKCG | 0.30468484 |
| 164 | MAPK1 | 0.28325330 |
| 165 | TNK2 | 0.27831057 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.89985125 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.65201178 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.53129844 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.52902392 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.32447039 |
| 6 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.19192064 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.18361053 |
| 8 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.05152984 |
| 9 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.04698659 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.03669313 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.78069672 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.77056695 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.76310232 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.73626728 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 1.69448215 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.68890349 |
| 17 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.65085258 |
| 18 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.57682761 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.53145510 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52953921 |
| 21 | Phototransduction_Homo sapiens_hsa04744 | 1.48274695 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.47351660 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.44776326 |
| 24 | Nicotine addiction_Homo sapiens_hsa05033 | 1.44629384 |
| 25 | ABC transporters_Homo sapiens_hsa02010 | 1.44045760 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43798010 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.42545328 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.39330791 |
| 29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.34029103 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.33902375 |
| 31 | Leishmaniasis_Homo sapiens_hsa05140 | 1.28926139 |
| 32 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.28769289 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.27935493 |
| 34 | Taste transduction_Homo sapiens_hsa04742 | 1.24281110 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.23500524 |
| 36 | Lysosome_Homo sapiens_hsa04142 | 1.23217826 |
| 37 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.22997414 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.22619865 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20334116 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 1.20176535 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.19945635 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.18380542 |
| 43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.18223591 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.17058592 |
| 45 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.12586707 |
| 46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12581001 |
| 47 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.12381290 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.11418464 |
| 49 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.09376862 |
| 50 | Morphine addiction_Homo sapiens_hsa05032 | 1.08826163 |
| 51 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.08509072 |
| 52 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.07159066 |
| 53 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06713200 |
| 54 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.06701332 |
| 55 | Circadian entrainment_Homo sapiens_hsa04713 | 1.05063611 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.02897631 |
| 57 | Circadian rhythm_Homo sapiens_hsa04710 | 0.98429576 |
| 58 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.97281367 |
| 59 | Long-term depression_Homo sapiens_hsa04730 | 0.97090003 |
| 60 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.96120491 |
| 61 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.94019337 |
| 62 | Allograft rejection_Homo sapiens_hsa05330 | 0.92982654 |
| 63 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92977088 |
| 64 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.92746927 |
| 65 | Retinol metabolism_Homo sapiens_hsa00830 | 0.92192249 |
| 66 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.92014188 |
| 67 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.91201638 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90813416 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.90623828 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.90539331 |
| 71 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.89438683 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.89297388 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.89022584 |
| 74 | Insulin secretion_Homo sapiens_hsa04911 | 0.88746921 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.88700405 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88111021 |
| 77 | Olfactory transduction_Homo sapiens_hsa04740 | 0.88100309 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.87856769 |
| 79 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.87483995 |
| 80 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.85478259 |
| 81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.85322151 |
| 82 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.84575232 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83402865 |
| 84 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.83172696 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82750549 |
| 86 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80617286 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.80560872 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79666775 |
| 89 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.79664309 |
| 90 | Renin secretion_Homo sapiens_hsa04924 | 0.77998242 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76419912 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75718922 |
| 93 | Measles_Homo sapiens_hsa05162 | 0.75424698 |
| 94 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.74100349 |
| 95 | Homologous recombination_Homo sapiens_hsa03440 | 0.73565725 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.71961523 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70920218 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69821047 |
| 99 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69756358 |
| 100 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.69401277 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69069870 |
| 102 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.67726576 |
| 103 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.67500710 |
| 104 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67357398 |
| 105 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.67160488 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65990938 |
| 107 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64331392 |
| 108 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64324398 |
| 109 | Legionellosis_Homo sapiens_hsa05134 | 0.64198610 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.63954118 |
| 111 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63736813 |
| 112 | Platelet activation_Homo sapiens_hsa04611 | 0.63617090 |
| 113 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.63232082 |
| 114 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62684352 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62428792 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61508694 |
| 117 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.61061826 |
| 118 | Tuberculosis_Homo sapiens_hsa05152 | 0.60217860 |
| 119 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59574195 |
| 120 | Influenza A_Homo sapiens_hsa05164 | 0.59317867 |
| 121 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.58781970 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | 0.58223365 |
| 123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57525504 |
| 124 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.57488800 |
| 125 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57476246 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57427529 |
| 127 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.57330855 |
| 128 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57218952 |
| 129 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56825197 |
| 130 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.56724155 |
| 131 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56377226 |
| 132 | GABAergic synapse_Homo sapiens_hsa04727 | 0.56277765 |
| 133 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.55626335 |
| 134 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55437760 |
| 135 | Mineral absorption_Homo sapiens_hsa04978 | 0.55318597 |
| 136 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54951562 |
| 137 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.54783091 |
| 138 | Apoptosis_Homo sapiens_hsa04210 | 0.53809641 |
| 139 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53487157 |
| 140 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53403108 |
| 141 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.53258866 |
| 142 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53232314 |
| 143 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52988965 |
| 144 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52373727 |
| 145 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52370754 |
| 146 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51669902 |
| 147 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.51499923 |
| 148 | Malaria_Homo sapiens_hsa05144 | 0.51109748 |
| 149 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.50839755 |
| 150 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49955575 |
| 151 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49611743 |
| 152 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49469691 |
| 153 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48813052 |
| 154 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48508836 |
| 155 | Melanoma_Homo sapiens_hsa05218 | 0.48336429 |
| 156 | Carbon metabolism_Homo sapiens_hsa01200 | 0.48152741 |
| 157 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.48144392 |
| 158 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47834498 |
| 159 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.47761034 |
| 160 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.47297187 |
| 161 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.45235569 |
| 162 | Adherens junction_Homo sapiens_hsa04520 | 0.45157078 |
| 163 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.43596048 |
| 164 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41000546 |

